Dynocardia

Dynocardia

A fundamentally new way to accurately and continuously measure blood pressure (BP).

HQ location
Cambridge, United States
Launch date
Employees
Enterprise value
$6—9m
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
N/A

€0.0

round
investor

€0.0

round
investor

€0.0

round
*
N/A

$1.5m

Early VC
Total Funding000k
Notes (0)
More about Dynocardia
Made with AI
Edit

Dynocardia is a pioneering healthcare technology company focused on revolutionizing blood pressure (BP) monitoring. The company serves patients in intensive care units, hypertensive individuals, and healthcare providers who require accurate and continuous BP data. Operating in the medical device market, Dynocardia's core product is a wearable optomechanical sensor that allows for cuffless, ambulatory BP measurement. This innovative device not only measures BP continuously but also provides comprehensive data on respiration, heart rate, and cardiac hemodynamic parameters. The business model is centered around selling these advanced monitoring devices to hospitals, clinics, and individual consumers, generating revenue through direct sales and potential subscription services for data analytics. Dynocardia addresses critical flaws in traditional BP monitoring methods, such as inaccuracy and the inability to measure BP continuously, thereby reducing the risk of complications and incorrect diagnoses.

Keywords: wearable sensor, continuous monitoring, cuffless BP, cardiac health, hypertension, intensive care, medical device, optomechanical, healthcare technology, data analytics.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads